| LML-134 |
LML-134 |
1542135-76-1 |
| Mirvetuximab |
Mirvetuximab |
1453084-36-0 |
| Crotedumab |
Crotedumab |
1452387-69-7 |
| RO6885247) |
RG7800 |
1449598-06-4 |
| K145 (hydrochloride) |
3-(2-氨基乙基)-5-[3-(4-丁氧基苯基)亚丙基]-2,4-噻唑烷二酮盐酸盐 |
1449240-68-9 |
| Selonsertib HCl salt, GS-4997 HCl salt |
GS-4997 HCL SALT |
1448428-05-4 |
| Firivumab |
Firivumab |
1443004-15-6 |
| Ulocuplumab |
Ulocuplumab |
1375830-34-4 |
| Pritoxaximab |
Pritoxaximab |
1351470-16-0 |
| UNC569 |
CS-2399 |
1350547-65-7 |
| Clopidogrel hydrogen sulfate |
硫酸氢氯吡格雷 |
135046-48-9 |
| SR8278 |
SR8278;SR-8278;SR 8278 |
1254944-66-5 |
| 6-Quinazolinol, 4-[(3-chloro-4-fluorophenyl)amino]-7-(methoxy-d3)- |
4-((3-氯-4-氟苯基)氨基)-7-(甲氧基-D3)喹唑啉-6-醇 |
1228665-04-0 |
| L-Phenylalaninamide, N-[(2S)-2-(2,5-dioxo-1-pyrrolidinyl)-1-oxopropyl]-L-alanyl-L-prolyl-N-(4-nitrophenyl)- |
SUC-ALA-ALA-PRO-PHE-PNA |
107409-54-1 |
| Isobenzofuran, octahydro-, trans- (9CI) |
Isobenzofuran, octahydro-, trans- (9CI) |
10479-79-5 |
| PF-05231023 |
PF-05231023 |
1037589-69-7 |
| 4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinocytidine |
4-氨基-1-(4-C-叠氮基-2-脱氧-2-氟-BETA-D-呋喃阿拉伯糖基)-2(1H)-嘧啶酮 |
1011529-10-4 |
| Aminoxy-PEG4-acid |
羟胺-四乙二醇-羧酸 |
1807537-38-7 |
| LSP-249 |
LSP-249 |
1801253-04-2 |
| PLX5622 |
PLX5622 |
1303420-67-8 |
QQ
微信
